Nā huahana
-
ʻEiwa Respiratory Virus IgM Antibody
Hoʻohana ʻia kēia pahu no ka ʻike kōkua o ka in vitro qualitative detection of Respiratory syncytial virus, Adenovirus, Influenza A virus, Influenza B virus, Parainfluenza virus, Legionella pneumophila, M. Pneumonia, Q fever Rickettsia a me Chlamydia pneumoniae maʻi.
-
19 Nā ʻano ʻano o ka ʻakika Nucleic Acid Respiratory Pathogen
Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka qualitative hui ʻia o SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus a me ka maʻi parainfluenza (Ⅰ, II, III, IV) i loko o ka puʻu ʻāʻī. a me ka sputum samples, metapneumovirus kanaka, haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, legionella pneumophila a me acinetobacter baumannii.
-
Neisseria Gonorrhoeae Nucleic Acid
Hoʻolālā ʻia kēia pahu no ka ʻike in vitro o Neisseria Gonorrhoeae(NG) nucleic acid i loko o ka mimi kāne, ka urethral swab kāne, ka wahine cervical swab samples.
-
ʻEhā ʻano o nā mea hoʻomaʻi hanu nucleic acid
Hoʻohana ʻia kēia kit no ka ʻike qualitative o SARS-CoV-2, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā ʻano oropharyngeal swab samples.
-
ʻO ka Mycobacterium Tuberculosis Rifampicin Resistance
He kūpono kēia pahu no ka ʻike qualitative o ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.
-
Adenovirus Antigen
Kuhi ʻia kēia pahu no ka ʻike in vitro qualitative o Adenovirus(Adv) antigen i loko o nā swabs oropharyngeal a me nā swabs nasopharyngeal.
-
Respiratory Syncytial Virus Antigen
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka respiratory syncytial virus (RSV) fusion protein antigens ma nā nasopharyngeal a i ʻole oropharyngeal swab specimens mai nā neonates a i ʻole nā keiki ma lalo o 5 mau makahiki.
-
ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid
Hoʻohana ʻia kēia pahu no ka hoʻoholo ʻana i ka qualitative o nā waikawa nucleic i nā laʻana me ka serum a i ʻole ka plasma mai nā mea maʻi i manaʻo ʻia he maʻi HCMV, i mea e kōkua ai i ka hōʻoia ʻana o ka maʻi HCMV.
-
Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin Resistance
He kūpono kēia kit no ka ʻike qualitative o Mycobacterium tuberculosis DNA i loko o nā laʻana sputum kanaka i loko o ka vitro, a me ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.
-
Mycoplasma Hominis Nucleic Acid
He mea kūpono kēia kit no ka ʻike qualitative o Mycoplasma hominis (MH) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine.
-
Herpes Simplex Virus Type 1/2，(HSV1/2) Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Herpes Simplex Virus Type 1 (HSV1) a me Herpes Simplex Virus Type 2 (HSV2) e kōkua i ka hoʻomaʻamaʻa a mālama ʻana i nā poʻe maʻi i manaʻo ʻia he maʻi HSV.
-
Vitamin D
ʻO ka pahu ʻike vitamin D (colloidal gold) he kūpono ia no ka ʻike semi-quantitative o ka vitamina D i loko o ke koko venous kanaka, serum, plasma a i ʻole ke koko peripheral, a hiki ke hoʻohana ʻia e nānā i nā maʻi no ka hemahema o ka vitamina D.
